hotspot -WSS

hotspot

author：Wikipedia 2025-09-28 02:32:11 - browse：19816

Multiple syringes in a vial -- Pharma coverage from STAT — Adobe

Roughly two million Americans are expected to receive a cancer diagnosis this year. Some members of this already vulnerable group will wind up facing what physician Andrew Schuman recently called “a tragedy happening in slow motion” — an ongoing, nationwide shortage of critical oncology drugs that routinely save or extend the lives of children and adults.

Speaking at a March 22 Senate hearing on drug shortages, Schuman, a head and neck surgeon at the U.S. Department of Veterans Affairs, described the agonizing decisions that doctors must make when critical medicines are in short supply. “Should our limited vials go to an older woman who was just diagnosed with lung cancer? To a young man who had already been successfully taking it for his testicular cancer? Or a baby with neuroblastoma?” he asked. “As a doctor who has devoted my life to fighting cancer, it is hard to express how horrible it is to face this kind of tragedy.”

The dilemmas caused by cancer drug shortages are unfortunately nothing new. In the past decade alone, eight of the 10 drugs most commonly used to treat acute lymphoblastic leukemia, the most common kind of childhood cancer type of leukemia, have been temporarily unavailable. The problem has been getting worse: Nationwide shortages of critical drugs increased nearly 30% in 2022, soaring to their highest level in nearly five years, according to a report released by the Senate Homeland Security and Governmental Affairs Committee for the hearing. Oncology drugs currently in short supply include methotrexate, which treats breast and soft tissue cancers; cisplatin, which treats testicular, ovarian, bladder, head and neck, lung, and cervical cancers; fluorouracil, which treats skin cancer; Pluvicto, for prostate cancer; and the injectable bacillus Calmette-Guérin, for bladder cancer.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Walensky prepares to leave CDC — and Congress — behind
Next article： Mike Pence clashes with Tucker Carlson in Iowa

explore

WSS

Argenx drug significantly slows progression of nerve disorder

Key Senate panel to consider PBM, drug pricing reform package

Georgia court denies Trump's request to quash DA's 2020 election probe

Celiac disease study examines precisely how gluten triggers injury

How to convince healthy people to buy insurance

The new HIV moral panic

focus

hotspot

leisure time

DIEP, the 'gold standard' of breast reconstruction, is under threat

Humans aren't the only ones with an imagination. Rats have it too

Virginia high school admissions case could be legal follow

Medicare proceeds with plan to claw back hospital funds

Medicare proposal to cover medical devices draws a mixed reaction

Global childhood vaccinations edge closer to pre

Medical records are filled with copy

In Gaza, a nonprofit 3D prints tourniquets and stethoscopes

FDA approval of Sarepta Duchenne genetic therapy gives me hope

The new HIV moral panic

hotspot

Who gets to use the title 'doctor'?

Manchin, Huntsman team up to talk platform for 'unity' ticket that could run in 2024

How to convince healthy people to buy insurance

Life sciences investors close nearly $6 billion in new funds

Prime Medicine says its gene editing passes test in monkeys

Eli Lilly to acquire Versanis in heated race for weight loss drugs

Wikipedia

explore

explore

Wikipedia